Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3
by on Friday, July 6th, 2012 | No Comments
Condition: Cervical Intraepithelial Neoplasia Grade 3
Intervention: Genetic: GX-188 administered by electroporation
Sponsors: Genexine Co., Ltd.; Genexine Co., Ltd.
Not yet recruiting – verified July 2012
Read the original post: Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3